Back to Depression And Anxiety
NCT04352634
NCT04352634
Who may be able to join
Who might be able to join this trial:
- You must be of legal adult age.
- You must currently be working in a healthcare setting that provides care to COVID-19 patients.
- You must be willing to give your informed consent to take part in the study.
Who may not be able to join:
- You may not be able to take part if you are unable to use electronic devices, as these are needed to complete the survey.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
UNKNOWN
Phase
Not Applicable
Sponsor
University of Chile
Registry
clinicaltrials_gov
Start date
26 April 2020
Est. completion
31 December 2021
Where this trial is recruiting
🇦🇷 Argentina
Armenia
🇦🇺 Australia
Bolivia
🇨🇱 Chile
Costa Rica
🇨🇿 Czechia
🇩🇪 Germany
Guatemala
🇮🇹 Italy
🇱🇧 Lebanon
🇲🇽 Mexico
🇳🇱 Netherlands
Nigeria
Puerto Rico
🇸🇦 Saudi Arabia
🇪🇸 Spain
Tunisia
Turkey (Türkiye)
🇺🇸 United States
Venezuela
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Anxiety and depressive symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.